China Medicine Corp.
Other OTCTotal Valuation
China Medicine Corp. carries a market capitalization of 486,097.00, placing it among publicly traded companies globally.
| Market Cap | 486,097.00 |
| Enterprise Value | N/A |
Share Statistics
China Medicine Corp. currently has 23.71M shares outstanding.
| Shares Outstanding | 23.71M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
China Medicine Corp. trades at a trailing price-to-earnings ratio of 9.14. The price-to-sales ratio is 0.84, and the price-to-book ratio stands at 2.23.
| PE Ratio | 9.14 |
| PS Ratio | 0.84 |
| PB Ratio | 2.23 |
| P/TBV Ratio | 0.90 |
| P/FCF Ratio | 4.34 |
| P/OCF Ratio | 5.01 |
Financial Position
China Medicine Corp. maintains a current ratio of 11.15, meaning it holds 11.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 11.15 |
| Quick Ratio | 2.97 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | 23.72 |
| Return on Assets (ROA) | 6.45 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 6.33 |
Taxes
Over the trailing twelve months, China Medicine Corp. has paid 3.76M in income taxes, reflecting an effective tax rate of 39.67.
| Income Tax | 3.76M |
| Effective Tax Rate | 39.67 |
Stock Price Statistics
China Medicine Corp.'s stock has gained approximately 6733.33301% over the past 52 weeks. The 50-day moving average sits at 0.03, while the 200-day moving average is 0.03.
| Beta (5Y) | N/A |
| 52-Week Price Change | 6733.33301% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.03 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, China Medicine Corp. generated 65.75M in revenue and converted that into 6.03M in net income, yielding earnings per share of 0.17. EBITDA reached 13.41M, while operating income came in at 11.70M.
| Revenue | 65.75M |
| Gross Profit | 22.00M |
| Operating Income | 11.70M |
| Pretax Income | 9.48M |
| Net Income | 6.03M |
| EBITDA | 13.41M |
| EBIT | 11.70M |
| Earnings Per Share (EPS) | 0.17 |
Balance Sheet
Total book value stands at 24.76M, with working capital of 85.75M providing operational flexibility.
| Cash & Cash Equivalents | 7.85M |
| Total Debt | N/A |
| Net Debt | -4.65M |
| Equity (Book Value) | 24.76M |
| Book Value Per Share | 0.93 |
| Working Capital | 85.75M |
Cash Flow
China Medicine Corp. produced 11.01M in operating cash flow over the past twelve months. After subtracting -4.58M in capital expenditures, free cash flow totaled 6.43M - equivalent to 0.24 per share.
| Operating Cash Flow | 11.01M |
| Capital Expenditures | -4.58M |
| Free Cash Flow | 6.43M |
| FCF Per Share | 0.24 |
Margins
China Medicine Corp. operates with a gross margin of 33.46, reflecting its pricing power and cost economics. The operating margin of 17.80 and net profit margin of 9.17 provide insight into operational efficiency.
| Gross Margin | 33.46 |
| Operating Margin | 17.80 |
| Pretax Margin | 14.42 |
| Profit Margin | 9.17 |
| EBITDA Margin | 20.39 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -8.63 |
| FCF Yield | 23.04 |
Scores
China Medicine Corp. posts an Altman Z-Score of 2.65, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.65 |